• About ZoBio
  • Our Approach
  • Our Capabilities
  • Our Science
    • Case Studies
    • Publications and Posters
    • Science in the Cauldron
  • News
  • Events
  • Careers
  • Contact
Skip to content

News

23 October 2025

Expanding Isotopic Labeling in Mammalian Expression: Pushing the Boundaries on NMR Studies of Hard-to-Express Proteins

ZoBio is excited to expand its exclusive capability for making complex protein samples for drug discovery with 13C-methyl MILV isotopic labeling during HEK293 mammalian…

Read more
24 March 2025

Lipids Make a Difference: Local Collaboration Advances Drug Discovery for Membrane Proteins

Membrane proteins are without a doubt an important drug target: about 60% of all confirmed drug targets are located on the cell surface. However, studying these proteins in vitro has long been challenging due to…

Read more
16 January 2025

Tackling the Hard-to-Drug Frontier: The Power of Complementary Screening Modalities

Developing small-molecule drugs for hard-to-drug targets remains one of the toughest challenges in modern drug discovery. Targets like cytokines, transcription factors, and scaffolding proteins often lack well-defined…

Read more
7 November 2024

Isotopic Labeling in Mammalian Expression: The Missing Link for NMR Studies of Hard-to-Express Proteins

ZoBio is excited to introduce a new exclusive capability for making complex protein samples for drug discovery: isotopic labeling during mammalian expression. This ability provides the missing link between…

Read more
1 2 3 … 7 Next »

Search

In news only

By year

Latest news

Expanding Isotopic Labeling in Mammalian Expression: Pushing the Boundaries on NMR Studies of Hard-to-Express Proteins

Lipids Make a Difference: Local Collaboration Advances Drug Discovery for Membrane Proteins

Tackling the Hard-to-Drug Frontier: The Power of Complementary Screening Modalities

Using SEC-MALS to Validate BRICHOS Oligomer Structures

We Are ZoBio

Innovative NMR Strategy Provides Structure of First-in-Class Small Molecule Inhibitors of the Dual-Specificity Kinase MKK4 (MKK4i)

Fragment-Based Lead Discovery as a Powerful Approach for Identifying Novel SOS2:KRAS PPI Inhibitors

Oncodesign Services Acquires ZoBio

ZoBio is a Crystallography Company (Too)

Innovative Application of the Hamilton Liquid Handler

Subscribe to our newsletter STAY TUNED!

Our tailor-made approach and tenacity will yield the right molecule for your target.

Contact us:

Privacy statement

ZoBio BV

J.H. Oortweg 19
2333 CH Leiden
The Netherlands
+31-71-2040580